Glaukos says late-stage eye disease treatment shows lasting benefits after single dose
- Posted on October 8, 2026
- By Bing News
- 0 Views
- 1 min read
In brief
Generating AI summary…
Glaukos says late-stage eye disease treatment shows lasting benefits after single dose
Oct 7 (Reuters) - Glaukos said on Wednesday patients treated with its late-stage eye disease therapy maintained improvements in vision and corneal shape three years after a single treatment for keratoconus, a disease that can progressively distort vision. • The medtech firm said patients who received a single Epioxa treatment did not require additional intervention during the three-year follow-up
